Despite the high mutation frequency of FMGs in CRC, there were no significant differences in TMB between SCG2-expressing subgroups and no statistically significant correlation analysis between TMB and SCG2 (Figures S3A, B). This evidence concerns the gene SCG2 and colorectal carcinoma.